Gene Expression of the Tumour Suppressor LKB1 Is Mediated by Sp1, NF-Y and FOXO Transcription Factors

The serine/threonine kinase LKB1 is a tumour suppressor that regulates multiple biological pathways, including cell cycle control, cell polarity and energy metabolism by direct phosphorylation of 14 different AMP-activated protein kinase (AMPK) family members. Although many downstream targets have been described, the regulation of LKB1 gene expression is still poorly understood. In this study, we performed a functional analysis of the human LKB1 upstream regulatory region. We used 200 base pair deletion constructs of the 5′-flanking region fused to a luciferase reporter to identify the core promoter. It encompasses nucleotides −345 to +52 relative to the transcription start site and coincides with a DNase I hypersensitive site. Based on extensive deletion and substitution mutant analysis of the LKB1 promoter, we identified four cis-acting elements which are critical for transcriptional activation. Using electrophoretic mobility shift assays as well as chromatin immunoprecipitations, we demonstrate that the transcription factors Sp1, NF-Y and two forkhead box O (FOXO) family members FOXO3 and FOXO4 bind to these elements. Overexpression of these factors significantly increased the LKB1 promoter activity. Conversely, small interfering RNAs directed against NF-Y alpha and the two FOXO proteins greatly reduced endogenous LKB1 expression and phosphorylation of LKB1's main substrate AMPK in three different cell lines. Taken together, these results demonstrate that Sp1, NF-Y and FOXO transcription factors are involved in the regulation of LKB1 transcription.

[1]  V. McKusick,et al.  Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. , 1949, The New England journal of medicine.

[2]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  P Chambon,et al.  Promoter sequences of eukaryotic protein-coding genes. , 1980, Science.

[4]  C. Der,et al.  Human cell hybrids: analysis of transformation and tumorigenicity. , 1982, Science.

[5]  C. Benoist,et al.  A multiplicity of CCAAT box-binding proteins , 1987, Cell.

[6]  H. Thiesen,et al.  Target Detection Assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. , 1990, Nucleic acids research.

[7]  P. Carlsson,et al.  Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. , 1994, The EMBO journal.

[8]  K. Wright,et al.  Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y (*) , 1995, The Journal of Biological Chemistry.

[9]  S. Daniel,et al.  Sp1 Mediates Glucose Activation of the Acetyl-CoA Carboxylase Promoter (*) , 1996, The Journal of Biological Chemistry.

[10]  J. Nezu,et al.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. , 1998, Nature genetics.

[11]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[12]  Y. Nishizuka,et al.  Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Suske The Sp-family of transcription factors. , 1999, Gene.

[14]  Geert J. P. L. Kops,et al.  Direct control of the Forkhead transcription factor AFX by protein kinase B , 1999, Nature.

[15]  D. Hardie,et al.  AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. , 1999, The Biochemical journal.

[16]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[17]  R. Mantovani,et al.  The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.

[18]  G. Velasco,et al.  FHX, a Novel Fork Head Factor with a Dual DNA Binding Specificity* , 2000, The Journal of Biological Chemistry.

[19]  T. Nakazawa,et al.  Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. , 2000, The Biochemical journal.

[20]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[21]  J. Herman,et al.  Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome , 2000, Oncogene.

[22]  C. Martínez-A,et al.  Forkhead transcription factors contribute to execution of the mitotic programme in mammals , 2001, Nature.

[23]  Brian A. Hemmings,et al.  Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.

[24]  M. Seldin,et al.  Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. , 2002, Cancer research.

[25]  David Sidransky,et al.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.

[26]  Jérôme Boudeau,et al.  Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade , 2003, Journal of biology.

[27]  H. T. Kang,et al.  Down-regulation of Sp1 Activity through Modulation of O-Glycosylation by Treatment with a Low Glucose Mimetic, 2-Deoxyglucose* , 2003, Journal of Biological Chemistry.

[28]  B. Kemp Faculty Opinions recommendation of Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. , 2003 .

[29]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[30]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Hiroshi Handa,et al.  NF-Y Is Essential for the Recruitment of RNA Polymerase II and Inducible Transcription of Several CCAAT Box-Containing Genes , 2005, Molecular and Cellular Biology.

[32]  H. Hausen,et al.  Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells* , 2005, Journal of Biological Chemistry.

[33]  P. Propping,et al.  High proportion of large genomic STK11 deletions in Peutz‐Jeghers syndrome , 2005, Human mutation.

[34]  Kei Sakamoto,et al.  LKB1-dependent signaling pathways. , 2006, Annual review of biochemistry.

[35]  F. Colland,et al.  FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP , 2006, Nature Cell Biology.

[36]  Wei Wu,et al.  Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. , 2006, Molecular endocrinology.

[37]  William Stafford Noble,et al.  Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays , 2006, Nature Methods.

[38]  L. Aaltonen,et al.  LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome , 2005, Journal of Medical Genetics.

[39]  J. De-Castro Arce,et al.  Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region* , 2007, Journal of Biological Chemistry.

[40]  D. Saur,et al.  Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. , 2007, Cancer research.

[41]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[42]  S. Gygi,et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.

[43]  J. De-Castro Arce,et al.  Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1. , 2007, The Biochemical journal.

[44]  B. Burgering,et al.  Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.

[45]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[46]  V. Bhardwaj,et al.  Tumour necrosis factor‐α attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells , 2009, The FEBS journal.

[47]  M. Gerstein,et al.  Unlocking the secrets of the genome , 2009, Nature.

[48]  B. Lahn,et al.  Systematic identification of cis-silenced genes by trans complementation , 2008, Human molecular genetics.

[49]  W. Hahn,et al.  SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis , 2009, Science Signaling.

[50]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[51]  Kwok-Kin Wong,et al.  Somatic LKB1 Mutations Promote Cervical Cancer Progression , 2009, PloS one.

[52]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.